Sandercock Colin bought CUE
December 3, 2025 · Form 4 insider transaction
Sandercock Colin bought 70,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
70,000
Price
$0.00
Total value
N/A
InsiderSandercock Colin
RoleOfficer
CompanyCue Biopharma, Inc. (CUE)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 3, 2025
Filing dateDecember 5, 2025
Shares owned after70,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on December 3, 2025 and these shares underlying the option vested.